An Antibody-Tumor Necrosis Factor Fusion Protein that Synergizes with Oxaliplatin for Treatment of Colorectal Cancer.

Bajic, Davor; Chester, Kerry; Neri, Dario

Bajic, Davor; Chester, Kerry; Neri, Dario.

Afiliação

Bajic D; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zürich, Switzerland.
Chester K; UCL Cancer Institute, University College London, London, England, United Kingdom.
Neri D; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Zürich, Switzerland. dario.neri@pharma.ethz.ch.

Mol Cancer Ther ; 19(12): 2554-2563, 2020 12.

Article em En | MEDLINE | ID: mdl-32999042

Assuntos

Antineoplásicos/farmacologia; Oxaliplatina/farmacologia; Proteínas Recombinantes de Fusão/farmacologia; Animais; Linhagem Celular Tumoral; Neoplasias do Colo; Fluoruracila/farmacologia; Humanos; Camundongos; Anticorpos de Cadeia Única/genética; Fator de Necrose Tumoral alfa/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Oxaliplatina / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google